Doc2Doc

Doc2Doc is a financial-services platform for those working in healthcare.

Physicians, dentists, pharmacists, veterinarians, optometrists — these may sound like professions that come with higher-than-average salaries and, therefore, a lack of financial problems.

But this group of 6.3 million faces unique challenges. While many will eventually earn six- and even seven-figure salaries, these high incomes aren’t guaranteed for everyone. And those that do likely won’t earn these amounts until later in their careers.

Many doctors and physicians enter the workforce with high student debt, modest resident incomes, and underdeveloped credit profiles. That makes it hard for them to achieve financial success and obtain loans.

Doc2Doc Lending was founded to provide doctors with a financial partner that truly understands their unique challenges. By leveraging physician-centric risk analysis that goes beyond a credit score, this company delivers expedited loans with competitive rates tailored to the medical community.

Benefits to Doc2Doc’s loans include:

Fast Approvals — A streamlined loan-application process.

Low Rates — Affordable loans with no hidden fees.

Financial Literacy — Resources to empower better decisions.

Transition Support — Loans designed to relocation and residency needs.

Expanding Reach — New offerings for pharmacists, vets, and optometrists.

This is a huge opportunity. U.S. healthcare financing is a sixteen-billion-dollar market and is projected to grow nearly forty percent with possible expansions including pharmacy, optometry, and veterinary medicine.

Doc2Doc holds a TrustPilot score of 4.9, with glowing reviews from doctors who praise the company’s seamless, transparent, tailored lending process.

Doc2Doc collaborates with more than fifty medical associations and networks. And its research on physician debt and financial performance has been presented at conferences including the Harvard Hospital System Grand Rounds and the American Society of Anesthesiologists meeting.

More than 3,500 doctors have obtained loans through Doc2Doc valued at more than $136 million.

Team Background

Zwade Marshall - Co-Founder & CEO

Zwade is an Emory- and Harvard-trained anesthesiologist and interventional pain-management specialist. His experience in healthcare gives him personal knowledge with respect to financial issues doctors and those in healthcare face.

In addition to his role with Doc2Doc, he is Founder and Chief Medical Officer of Regenerative Spine & Pain Specialists, a business treating those with chronic spine and joint pains. Previously, he was Director of Medical Outcomes at Alliance Spine & Pain Centers, a similar business.

Earlier in his career, Zwade worked at Brigham and Women’s Hospital for four years and before that was an operations associate with Emory Healthcare.

He earned a Bachelor’s degree in Economics, an MBA, and an MD from Emory University. He also completed his residency in Anesthesiology from Harvard Medical School.

Kenton Allen - Co-Founder & Board Member

In addition to his role with Doc2Doc, Kenton is the Vice Chairman at the Department of Anesthesiology at Wentworth-Douglass Hospital. Before that, he spent three years as a resident physician in anesthesiology at Brigham and Women’s Hospital.

For the past seven years, Kenton has been a member of the New Hampshire Medical Society. He earned a Bachelor’s degree in Biology from College of Holy Cross, and an MBA and MD from Dartmouth.

Chris Cronk - Chief Financial Officer

Chris has two decades of investment-banking experience and brings the financial knowledge that complements Doc2Doc’s co-founders’ medical expertise.

Prior to joining Doc2Doc, he owned Lendio Charlotte, a company helping local businesses secure financing through an online marketplace. Before that, he was a managing director with Bank of America Merrill Lynch.

Chris began his career as a vice president and later a managing director with Bank of America. He earned a Bachelor’s degree in Finance from Notre Dame and an MBA from the University of North Carolina Wilmington.

Co-Investors